Showing results (921-930 of 8,786) with videos related to

Sort By:
Pageof 879
Pediatric Blood & Cancer|January 26, 2007
Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213Sharon M Castellino, Todd A Alonzo, Allen Buxton, et al.
Pediatric Blood & Cancer|January 26, 2007
Toxicity and outcome of children with treatment related acute myeloid leukemiaUri Tabori, Giselle Revach, Paul C Nathan, et al.
Pediatric Blood & Cancer|April 18, 2007
Depressive symptoms and SSRI use in pediatric oncology patientsLeslie S Kersun, Josephine Elia
Pediatric Blood & Cancer|April 18, 2007
Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantationReo Tanoshima, Hiroaki Goto, Masakatsu Yanagimachi, et al.
Pediatric Blood & Cancer|May 3, 2007
Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of ageJoanna L Perkins, Alicia S Kunin-Batson, Nancy M Youngren, et al.
Pediatric Blood & Cancer|May 3, 2007
Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infectionNaoki Sakata, Naomi Toguchi, Masatomo Kimura, et al.
Pediatric Blood & Cancer|May 8, 2007
Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stayTrudie Goers, Julie Panepinto, Michael Debaun, et al.
Pediatric Blood & Cancer|March 17, 2007
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective studyNabil Ahmed, Hadir A El-Mahallawy, Ibrahim A Ahmed, et al.
Pediatric Blood & Cancer|March 17, 2007
Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocolsJudit Müller, Monika Csóka, Zsuzsanna Jakab, et al.
Pediatric Blood & Cancer|June 1, 2007
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study GroupMarcio Malogolowkin, Cecilia A Cotton, Daniel M Green, et al.
Pageof 879